Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
P Ruiz-Garbajosa, R Cantón - Revista Espanola de …, 2017 - search.ebscohost.com
Pseudomonas aeruginosa is one of the major pathogens causing hospital-acquired
infections. It can easily develop antibiotic resistance through chromosomal mutations or by …
infections. It can easily develop antibiotic resistance through chromosomal mutations or by …
Pseudomonas aeruginosa: Multi-drug-resistance development and treatment options
G Meletis, M Bagkeri - Infection Control, 2013 - books.google.com
Antibiotic resistance is a worldwide problem of major importance. Isolations in some
countries of multi-drug-resistant (resistant to three or more classes of antimicrobials) …
countries of multi-drug-resistant (resistant to three or more classes of antimicrobials) …
Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa
VH Tam, KT Chang, K Abdelraouf… - Antimicrobial agents …, 2010 - Am Soc Microbiol
Pseudomonas aeruginosa is an important pathogen commonly implicated in nosocomial
infections. The occurrence of multidrug-resistant (MDR) P. aeruginosa strains is increasing …
infections. The occurrence of multidrug-resistant (MDR) P. aeruginosa strains is increasing …
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa… - Antimicrobial agents …, 2012 - Am Soc Microbiol
Recent reports have revealed the existence of widespread extensively drug-resistant (XDR)
P. aeruginosa high-risk clones in health care settings, but there is still scarce information on …
P. aeruginosa high-risk clones in health care settings, but there is still scarce information on …
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa
isolates are frequent causes of serious nosocomial infections that may compromise the …
isolates are frequent causes of serious nosocomial infections that may compromise the …
The increasing threat of Pseudomonas aeruginosa high-risk clones
The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …
Multi-drug resistant Pseudomonas aeruginosa: towards a therapeutic dead end?
F Barbier, M Wolff - Medecine Sciences: M/S, 2010 - europepmc.org
Pseudomonas aeruginosa is a major hospital-associated pathogen that can cause severe
infections, most notably in patients with cystic fibrosis or those hospitalized in intensive care …
infections, most notably in patients with cystic fibrosis or those hospitalized in intensive care …
Multidrug and Extensive Drug Resistance in Pseudomonas aeruginosa Clinical Isolates from a Portuguese Central Hospital: 10-Year Survey
SG Pereira, M Marques, J Pereira… - Microbial Drug …, 2015 - liebertpub.com
Multidrug-resistant (MDR) Pseudomonas aeruginosa isolates are increasing worldwide and
greatly limit therapeutic options, particularly when considering extensively drug-resistant …
greatly limit therapeutic options, particularly when considering extensively drug-resistant …
[HTML][HTML] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy
J Mensa, J Barberán, A Soriano, P Llinares… - Revista Española de …, 2018 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa is characterized by a notable intrinsic resistance to antibiotics,
mainly mediated by the expression of inducible chromosomic β-lactamases and the …
mainly mediated by the expression of inducible chromosomic β-lactamases and the …
Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact
V Aloush, S Navon-Venezia… - Antimicrobial agents …, 2006 - Am Soc Microbiol
Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …